Current Assets Changement Date
Adcock Ingram Holdings ZAR 4.61B 127.84M 2023-06
Celltrion KRW 5.01T 1.61T 2023-12
Deva Holding AS TRY 9.13B 1.61B 2023-09
Ecofibre AUD 21.63M 5.98M 2023-06
Eli Lilly USD 23.01B 1.68B 2023-09
Kangmei Pharma CNY 7.02B 49M 2023-09
Knight Therapeutics CAD 401.3M 15.93M 2023-09
Laboratorios Farma EUR 637.96M 14.89M 2023-06
Magenta Therapeutics USD 191.45M 112.82M 2023-09
Malin Corporation EUR 32.8M 142.3M 2023-06
Medical Developments International AUD 42.76M 11.88M 2023-06
Nektar Therapeutics USD 399.02M 42.03M 2023-09
Neuren Pharmaceuticals AUD 96.4M 53.15M 2023-06
Organigram Holdings CAD 180.4M 23.64M 2023-03
Ovoca Bio EUR 4.96M 2.06M 2022-06
Pacira USD 509.99M 62.74M 2023-12
Perrigo USD 2.77B 7.7M 2023-09
Pharma Mar EUR 260.97M 6.87M 2023-09
Probiotec AUD 75.67M 603.45K 2023-06
Qiagen NV USD 1.96B 349.04M 2023-09
Sartorius EUR 2.02B 36M 2023-09
Sino Biopharmaceutical CNY 26.98B 1.04B 2023-06
Supernus Pharmaceuticals USD 493.11M 43.75M 2023-12
Zz Pientze Pharmaceu 14.13B 141.28M 2023-09



Xeris Pharmaceuticals Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.